Author:
Zahra Zahid Piracha,Sadia Mansha,Amna Naeem,Umar Saeed,Muhammad Nouman Tariq,Azka Sohail,Kashfia Hassan,Muhammad Waseem,Muhammad Shahmeer Fida Rana,Syed Shayan Gilani,Seneen Noor,Elyeen Noor
Abstract
Catheter-Related Bloodstream Infections (CRBSIs) are severe healthcare-associated complication that occurs when bacteria enter the bloodstream through a catheter. The risk of CRBSIs is influenced by various factors. Prolonged catheter placement increases the risk, as each day increases the potential for bacterial colonization and bloodstream infection. Proper aseptic technique and a sterile environment during catheter insertion are essential to minimize infection risk. Stringent infection control measures during insertion, including sterile gloves, thorough hand hygiene, and appropriate skin disinfection, are crucial. Inadequate catheter site care and suboptimal catheter management can contribute to CRBSIs. Regular cleaning, disinfection, and dressing changes are necessary to reduce the risk of infection. The type of catheter used also affects infection risk. Central Venous Catheters (CVCs) and arterial catheters, especially those inserted into the jugular or subclavian vein, carry a higher risk of CRBSIs compared to peripheral venous catheters. Individuals with compromised immune systems, such as chemotherapy patients, organ transplant recipients, and those with HIV/AIDS, are more susceptible to CRBSIs. Patients with existing infections, like pneumonia or urinary tract infections, are at a heightened risk of acquiring CRBSIs due to potential cross-contamination. Healthcare professionals who fail to practice thorough hand hygiene before and after catheter-related procedures can introduce pathogens into the bloodstream. Leaving catheters in place when no longer necessary or using them unnecessarily elevates the risk of infection. To prevent CRBSIs, strict infection control protocols, including effective hand hygiene, sterile catheter insertion techniques, routine site care, and prompt catheter removal when no longer needed, are imperative. Healthcare facilities often implement specific protocols to mitigate CRBSI risk and enhance patient safety.
Publisher
Heighten Science Publications Corporation
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference47 articles.
1. 1. Global Burden of Disease 2021 Health Financing Collaborator Network. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Glob Health. 2023 Mar;11(3):e385-e413. doi: 10.1016/S2214-109X(23)00007-4. Epub 2023 Jan 24. PMID: 36706770; PMCID: PMC9998276.
2. 2. GBD 2019 Pakistan Collaborators. The state of health in Pakistan and its provinces and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2023 Feb;11(2):e229-e243. doi: 10.1016/S2214-109X(22)00497-1. PMID: 36669807; PMCID: PMC10009760.
3. 3. Nejadghaderi SA, Moghaddam SS, Azadnajafabad S, Rezaei N, Rezaei N, Tavangar SM, Jamshidi H, Mokdad AH, Naghavi M, Farzadfar F, Larijani B; GBD 2019 NAME Thyroid Cancer Collaborators. Burden of thyroid cancer in North Africa and Middle East 1990-2019. Front Oncol. 2022 Sep 23; 12:955358. doi: 10.3389/fonc.2022.955358. Erratum in: Front Oncol. 2023 Apr 28; 13:1208646. PMID: 36212501; PMCID: PMC9538696.
4. 4. Saeed U, Piracha ZZ, Uppal SR, Waheed Y, Uppal R. SARS-CoV-2 induced hepatic injuries and liver complications. Front Cell Infect Microbiol. 2022 Sep 16; 12:726263. doi: 10.3389/fcimb.2022.726263. PMID: 36189356; PMCID: PMC9523111.
5. 5. GBD 2019 LRI Collaborators. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis. 2022 Nov;22(11):1626-1647. doi: 10.1016/S1473-3099(22)00510-2. Epub 2022 Aug 11. PMID: 35964613; PMCID: PMC9605880.